What question did this study set out to answer?

This research aims to evaluate the long-term effects of anti-VEGF treatment on visual and anatomical outcomes in patients with choroidal osteoma and associated CNV.

April 1, 2026Journal of RetinaOpen Access

Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in Choroidal Osteoma: A Pilot Study

View Full Paper

Ask AI

Bookmark

Authors

HSHyo Jin SeongYonsei University CLC. Justin LeeDaejeon University

Discussion

Member takes

Implication

Pilot study demonstrates visual and anatomical outcomes in choroidal osteoma cases, highlighting the need for ongoing monitoring.

Key Points

This research aims to evaluate the long-term effects of anti-VEGF treatment on visual and anatomical outcomes in patients with choroidal osteoma and associated CNV.
Retrospective review of patients treated with anti-VEGF injections from 2005 to 2023
Collected data on demographics, visual acuity, CNV characteristics, and treatment outcomes
Analyzed recurrence rates and prognostic factors using multivariable logistic regression
88.2% of eyes achieved anatomical control post-treatment
Only 23.5% showed a notable improvement in visual acuity
70.6% of eyes experienced recurrences, primarily within the first year
Worse initial visual acuity linked to poorer prognosis

Cite This Study

Seong et al. (2026) studied this question.

synapsesocial.com/papers/69ccb55116edfba7beb8758d https://doi.org/10.21561/jor.2026.11.1.13

View Full Paper

Ask AI

Bookmark

Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in Choroidal Osteoma: A Pilot Study

Discussion

Member takes

Implication

Key Points

Cite This Study

Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in Choroidal Osteoma: A Pilot Study

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider